Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Castlight Health, inc. CSLT

Growth Flags show if company had growth for consecutive years

Financial statements are limited to most recent four years or quarters for non-powerpack users

Ten years worth of data (where available), most important trends and XLS exports are available for our Powerpack users.
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
P/E ratio
0.00
0.00
0.00
0.00
‡‡‡
P/S ratio
5.05
3.61
1.91
1.35
‡‡‡‡‡
P/FCF ratio
0.00
0.00
0.00
0.00
‡‡‡
P/Operating CF
(291.78)
(5,962.86)
39.81
48.37
‡‡‡‡‡
P/B ratio
4.89
2.25
1.53
1.12
‡‡‡‡‡
Price to Tangible BV
4.89
4.79
3.45
2.80
‡‡‡‡‡
EV/Sales
3.89
2.94
1.44
1.00
‡‡‡‡‡
EV/EBITDA
0.00
0.00
0.00
0.00
‡‡‡‡‡
EV/Operating CF
(10.40)
(16.57)
(12.11)
(8.21)
‡‡‡‡‡
EV/FCF
(9.94)
(14.95)
(10.93)
(7.38)
‡‡‡‡‡
Quick Ratio
2.66
2.02
2.04
1.65
‡‡‡‡‡
Current Ratio
2.89
2.09
2.11
1.74
‡‡‡‡‡
Net Debt/EBITDA
2.45
2.39
4.76
2.56
‡‡‡‡‡
Debt/Assets
0.00%
1.77%
2.02%
3.78%
‡‡‡‡‡
Debt/Equity
0.00
0.02
0.03
0.05
‡‡‡‡‡
Asset Turnover
0.60
0.60
0.59
0.58
‡‡‡‡‡
Operating CF/Net income
0.63
0.45
0.47
0.43
‡‡‡‡‡
Capex/Depreciation
(0.14)
(0.12)
(0.08)
(0.09)
‡‡‡‡‡
Depreciation/Fixed assets
2.33
3.95
6.24
4.47
‡‡‡‡‡
Interest Coverage
0.00
0.00
0.00
0.00
‡‡‡
ROE
(53.27%)
(33.11%)
(19.55%)
(21.77%)
‡‡‡‡‡
ROA
(35.52%)
(23.75%)
(14.89%)
(16.12%)
‡‡‡‡‡
ROIC
0.00%
(29.29%)
(20.36%)
(21.07%)
‡‡‡‡‡
Cash ROIC
(19.51%)
(9.27%)
(8.12%)
(9.21%)
‡‡‡‡‡
Return on Tangible Assets
(60.15%)
(76.87%)
(65.51%)
(88.07%)
‡‡‡‡‡
Accounts Receivable Turnover
7.16
7.19
6.42
4.92
‡‡‡‡‡
Accounts Payable Turnover
11.24
15.06
8.94
4.05
‡‡‡‡‡
Inventory Turnover
0.00
0.00
0.00
0.00
‡‡‡
Average Days of Receivables
54.75
60.64
62.58
79.97
‡‡‡‡‡
Average Days of Payables
26.21
30.57
57.95
121.08
‡‡‡‡‡
Days of Inventory on Hand
0.00
0.00
0.00
0.00
‡‡‡
Research and Development Expense of Revenue
40.99%
41.28%
39.23%
41.17%
‡‡‡‡‡
Selling, General and Administrative Expense of Revenue
86.62%
67.10%
47.80%
46.46%
‡‡‡‡‡
Intangible Assets out of Total Assets
0.00
0.40
0.43
0.43
‡‡‡‡‡
Share Based Compensation of Revenue
21.53%
18.18%
11.59%
10.47%
‡‡‡‡‡
Graham Net Nets
0.17
0.11
0.16
0.13
‡‡‡‡‡
Graham Number
0.00
0.00
0.00
0.00
‡‡‡
Earnings Yield
(11.92%)
(11.84%)
(13.36%)
(20.30%)
‡‡‡‡‡
Free Cash Flow Yield
(7.75%)
(5.45%)
(6.88%)
(10.02%)
‡‡‡‡‡
Revenue per Share
0.98
1.05
1.14
0.99
‡‡‡‡‡
Operating CF per Share
(0.37)
(0.19)
(0.13)
(0.12)
‡‡‡‡‡
Capex per Share
(0.02)
(0.02)
(0.01)
(0.01)
‡‡‡‡‡
Free Cash Flow per Share
(0.38)
(0.21)
(0.15)
(0.13)
‡‡‡‡‡
Cash per Share
1.14
0.74
0.56
0.41
‡‡‡‡‡
Shareholders Equity per Share
1.01
1.69
1.41
1.19
‡‡‡‡‡
Interest Debt per Share
0.00
0.00
0.00
0.00
‡‡‡‡‡
Book value per Share
1.01
1.69
1.41
1.19
‡‡‡‡‡
Free Cash Flow
(38.67)
(26.00)
(20.56)
(19.34)
‡‡‡‡‡
Working Capital
92.29
62.26
56.65
40.56
‡‡‡‡‡
Capital Expenditures
(1.70)
(2.54)
(2.01)
(1.95)
‡‡‡‡‡
Net Current Asset Value
85.81
50.94
48.99
25.56
‡‡‡‡‡
Average Receivables
13.78
18.37
24.37
29.11
‡‡‡‡‡
Average Payables
2.84
3.10
6.73
14.58
‡‡‡‡‡
Average Assets
165.22
218.52
266.70
248.15
‡‡‡‡‡
Average Common Equity
110.16
156.76
203.11
183.77
‡‡‡‡‡
EV/EBIT
0.00
0.00
0.00
0.00
‡‡‡
Capex to Sales
0.02
0.02
0.01
0.01
‡‡‡‡‡
Net Profit Margin
(59.45%)
(39.31%)
(25.39%)
(27.91%)
‡‡‡‡‡
Price to Operating Income
0.00
0.00
0.00
0.00
‡‡‡
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us